GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Gross Margin %

Y-Biologics (XKRX:338840) Gross Margin % : 64.38% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Y-Biologics's Gross Profit for the three months ended in Mar. 2024 was ₩736 Mil. Y-Biologics's Revenue for the three months ended in Mar. 2024 was ₩1,143 Mil. Therefore, Y-Biologics's Gross Margin % for the quarter that ended in Mar. 2024 was 64.38%.

Warning Sign:

Y-Biologics Inc gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


The historical rank and industry rank for Y-Biologics's Gross Margin % or its related term are showing as below:

XKRX:338840' s Gross Margin % Range Over the Past 10 Years
Min: 29.87   Med: 44.99   Max: 84.84
Current: 76.67


During the past 6 years, the highest Gross Margin % of Y-Biologics was 84.84%. The lowest was 29.87%. And the median was 44.99%.

XKRX:338840's Gross Margin % is ranked better than
70.53% of 750 companies
in the Biotechnology industry
Industry Median: 60.53 vs XKRX:338840: 76.67

Y-Biologics had a gross margin of 64.38% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Y-Biologics was -1.30% per year.


Y-Biologics Gross Margin % Historical Data

The historical data trend for Y-Biologics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Gross Margin % Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial 29.87 40.71 84.84 49.26 32.20

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only 38.55 63.00 85.88 76.40 64.38

Competitive Comparison of Y-Biologics's Gross Margin %

For the Biotechnology subindustry, Y-Biologics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Y-Biologics's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-Biologics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Y-Biologics's Gross Margin % falls into.



Y-Biologics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Y-Biologics's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=1336.5 / 4150.558
=(Revenue - Cost of Goods Sold) / Revenue
=(4150.558 - 2814.101) / 4150.558
=32.20 %

Y-Biologics's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=735.7 / 1142.665
=(Revenue - Cost of Goods Sold) / Revenue
=(1142.665 - 406.984) / 1142.665
=64.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Y-Biologics  (XKRX:338840) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Y-Biologics had a gross margin of 64.38% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Y-Biologics Gross Margin % Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Y-Biologics (XKRX:338840) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines